# An Evaluation of Etanercept in the Treatment of Subjects With Psoriasis

> **NCT00111111** · PHASE3 · COMPLETED · sponsor: **Amgen**

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** Etanercept

## Key facts

- **NCT ID:** NCT00111111
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2009-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00111111

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00111111, "An Evaluation of Etanercept in the Treatment of Subjects With Psoriasis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00111111. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*